Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Enabling Total Biopharma Solutions
Pall Life Sciences
Navigating Technology Transfer
Beyond Quality: PAT as a Catalyst for Carbon Reduction in Pharma
Bristol Myers Squibb adopts positive CHMP opinion for Opdivo plus Yervoy for patients with Microsatellite instability high or mismatch repair deficient metastatic colorectal cancer
Bristol Myers Squibb
View All Featured ArticlesHeadline News
Health Canada authorizes Moderna’s mRNA flu and combination flu-COVID vaccines
FDA places Bright Minds’ planned BMB-101 Phase II epilepsy study on partial clinical hold
Intranasal foralumab reduces microglial activation in Phase IIa progressive MS trial
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Challenges and Risks in Development and Manufacture of Covid 19 Vaccines
Presented by Rajesh K. Gupta, Ph.D. Biologics Quality & Regulatory Consultants, LLC, North Potomac, Harish Rao, General Manager at Serum Institute of India Ltd, Amar Shrivastava, Senior Manager at Serum Institute of India Ltd
30th June 2020
Best Practices of Downstream Protein Purification and Product Concentration
Presented by Krishnamurthy Venkatesan, Downstream MSAT Lead, Director at Biocon Biologics, Sofie Östemar, Product Manager for Connected & Continuous Downstream Processing and Henrik Ihre, Ph.D. Director Strategic Technologies at Cytiva and Nigel Jackson Principal Engineer, Bioprocessing R&D at Pall Corporation
12th October 2022
Towards Real Time Release testing: Dissolution prediction of tablets made using Continuous Direct Compression
Presented by Pallavi Pawar of GlaxoSmithKline
21st November 2017
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Amsphere TM A3
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Best Practices for Achieving Virus Safety
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
